Šw‰ï”•\2022
Masaru Inatani
Live Imaging for the Enhanced Trabecular Aqueous Outflow After the Topical Administration of ROCK Inhibitor Antiglaucoma Ophthalmic Solution in the Human Eye
The 38th APAO Congress February23-26,2023 Malaysia, Kuala Lumpur Convention Center
Live Imaging for the Enhanced Trabecular Aqueous Outflow After the Topical Administration of ROCK Inhibitor Antiglaucoma Ophthalmic Solution in the Human Eye
The 38th APAO Congress February23-26,2023 Malaysia, Kuala Lumpur Convention Center
Takehiro Matsumura
Long-Term Outcome after Superficial Karatectomy for Partial Limbal Stem Cell Deficiency
The 15th Joint Meeting of Chinese-Japanese-Korean Ophthalmologists Virtual Meeting@Septermber11,2022 WEB
Long-Term Outcome after Superficial Karatectomy for Partial Limbal Stem Cell Deficiency
The 15th Joint Meeting of Chinese-Japanese-Korean Ophthalmologists Virtual Meeting@Septermber11,2022 WEB
Shogo Arimura
Chronic Antioxidant Capacity Loss in Anterior Chamber Environment After Iridectomy
The 15th Joint Meeting of Chinese-Japanese-Korean Ophthalmologists Virtual Meeting Septermber11,2022 WEB
Chronic Antioxidant Capacity Loss in Anterior Chamber Environment After Iridectomy
The 15th Joint Meeting of Chinese-Japanese-Korean Ophthalmologists Virtual Meeting Septermber11,2022 WEB
Masaru Inatani
Aqueous column changes in the episcleral veins after the instillation of ripasudil versus latanoprost: A randomized, double-blind, crossover clinical trial
The 38th APAO Congres February23-26,2023 Malaysia, Kuala Lumpur Convention Center
Aqueous column changes in the episcleral veins after the instillation of ripasudil versus latanoprost: A randomized, double-blind, crossover clinical trial
The 38th APAO Congres February23-26,2023 Malaysia, Kuala Lumpur Convention Center
Yutaka Yamada
Regional Variety of Reduction in Retinal Thickness of Diabetic Macular Edema after Anti-VEGF Treatment
The 15th Joint Meeting of Chinese-Japanese-Korean Ophthalmologists Virtual Meeting@Septermber11,2022 WEB
Regional Variety of Reduction in Retinal Thickness of Diabetic Macular Edema after Anti-VEGF Treatment
The 15th Joint Meeting of Chinese-Japanese-Korean Ophthalmologists Virtual Meeting@Septermber11,2022 WEB
‚‘º@‰ÀO
DME(DR)@
‘æ38‰ñ“ú–{ŠázŠÂŠw‰ï
—ߘa4”N7ŒŽ16-17“ú@•xŽR‘Û‰ï‹cê
@DME(DR)@
‘æ38‰ñ“ú–{ŠázŠÂŠw‰ï
—ߘa4”N7ŒŽ16-17“ú@•xŽR‘Û‰ï‹cê
—L‘º@®Œå
‘OŠá•”OCT‚Å‚Ý‚é‹É’áNP—ΓàáŽèp
‘æ33‰ñ“ú–{—ΓàáŠw‰ï
—ߘa4”N9ŒŽ16-18“ú@ƒpƒVƒtƒBƒR‰¡•l
‘OŠá•”OCT‚Å‚Ý‚é‹É’áNP—ΓàáŽèp
‘æ33‰ñ“ú–{—ΓàáŠw‰ï
—ߘa4”N9ŒŽ16-18“ú@ƒpƒVƒtƒBƒR‰¡•l
Šâí•@Œ’‘¾˜Y
iStent‚̃tƒ@ƒNƒgƒ`ƒFƒbƒN
‘æ76‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï
—ߘa4”N10ŒŽ13-16“ú@“Œ‹ž‘ÛƒtƒH[ƒ‰ƒ€
iStent‚̃tƒ@ƒNƒgƒ`ƒFƒbƒN
‘æ76‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï
—ߘa4”N10ŒŽ13-16“ú@“Œ‹ž‘ÛƒtƒH[ƒ‰ƒ€
îà‘º@‰ÀO
“O’ê“¢˜_I“œ”A•a–Ô–ŒÇE‰©”Á•‚ŽîŽ¡—Ã`‰·ŒÌ’mV`‚±‚Ì10”N‚Ìi•à‚ðŒŸØ‚·‚é
‘æ76‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï@ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX
—ߘa4”N10ŒŽ13-16“ú@“Œ‹ž‘ÛƒtƒH[ƒ‰ƒ€
“O’ê“¢˜_I“œ”A•a–Ô–ŒÇE‰©”Á•‚ŽîŽ¡—Ã`‰·ŒÌ’mV`‚±‚Ì10”N‚Ìi•à‚ðŒŸØ‚·‚é
‘æ76‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï@ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX
—ߘa4”N10ŒŽ13-16“ú@“Œ‹ž‘ÛƒtƒH[ƒ‰ƒ€
îà‘º@‰ÀO
“œ”A•a–Ô–ŒÇ‚Ìf’f`‘Šú‚Ì”ñNP“I‚Èf’f`
‘æ28‰ñ“ú–{“œ”A•aŠáŠw‰ï‘‰ï
—ߘa4”N10ŒŽ21“ú-22“ú@‘—§‹ž“s‘Û‰ïŠÙ
“œ”A•a–Ô–ŒÇ‚Ìf’f`‘Šú‚Ì”ñNP“I‚Èf’f`
‘æ28‰ñ“ú–{“œ”A•aŠáŠw‰ï‘‰ï
—ߘa4”N10ŒŽ21“ú-22“ú@‘—§‹ž“s‘Û‰ïŠÙ
ˆî’J@‘å
—Γàá“_ŠáƒAƒhƒqƒAƒ‰ƒ“ƒX‚ÌŽÀ‘Ô@ƒAƒhƒqƒAƒ‰ƒ“ƒX`ŠmŽÀ‚È–òŒøŽÀŒ»‚Ì‚½‚ß‚É`
‘æ42‰ñ“ú–{Šá–ò—Šw‰ï
—ߘa4”N10ŒŽ29-30“ú@“Þ—ÇŽs
—Γàá“_ŠáƒAƒhƒqƒAƒ‰ƒ“ƒX‚ÌŽÀ‘Ô@ƒAƒhƒqƒAƒ‰ƒ“ƒX`ŠmŽÀ‚È–òŒøŽÀŒ»‚Ì‚½‚ß‚É`
‘æ42‰ñ“ú–{Šá–ò—Šw‰ï
—ߘa4”N10ŒŽ29-30“ú@“Þ—ÇŽs
ˆî’J@‘å
Š³ŽÒ‚³‚ñ‚ÉŠñ‚è“Y‚Á‚½—ΓàᎡ—ÃI
‘æ126‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï@çŽõ»–ò‹¤Ãƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[
—ߘa4”N4ŒŽ14-17“ú@‘åã‘Û‰ï‹cê
Š³ŽÒ‚³‚ñ‚ÉŠñ‚è“Y‚Á‚½—ΓàᎡ—ÃI
‘æ126‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï@çŽõ»–ò‹¤Ãƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[
—ߘa4”N4ŒŽ14-17“ú@‘åã‘Û‰ï‹cê
ˆî’J@‘å
’´‚—ŽÐ‰ï‚̗Γàá@–ò•¨Ž¡—Â͂±‚¤‚µ‚悤B
‘æ92‰ñ‹ãBŠá‰ÈŠw‰ï@@çŽõ»–ò‹¤ÃƒAƒtƒ^ƒk[ƒ“ƒZƒ~ƒi[
—ߘa4”N5ŒŽ27-29“ú@‰«“ꌧ
’´‚—ŽÐ‰ï‚̗Γàá@–ò•¨Ž¡—Â͂±‚¤‚µ‚悤B
‘æ92‰ñ‹ãBŠá‰ÈŠw‰ï@@çŽõ»–ò‹¤ÃƒAƒtƒ^ƒk[ƒ“ƒZƒ~ƒi[
—ߘa4”N5ŒŽ27-29“ú@‰«“ꌧ
ˆî’J@‘å
uŒoŒ±v‚ÆuƒGƒrƒfƒ“ƒXv‚ÉŠw‚ÔŒ«ŽÒ‚̗ΓàᎡ—Ã@
ŒoŒ±‚ƃGƒrƒfƒ“ƒX‚©‚çŠw‚ԗΓàá
‘æ33‰ñ“ú–{—ΓàáŠw‰ï@ƒ”ƒBƒAƒgƒŠƒX»–ò‹¤Ãƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[
—ߘa4”N9ŒŽ16-18“ú@ƒpƒVƒtƒBƒR‰¡•l
uŒoŒ±v‚ÆuƒGƒrƒfƒ“ƒXv‚ÉŠw‚ÔŒ«ŽÒ‚̗ΓàᎡ—Ã@
ŒoŒ±‚ƃGƒrƒfƒ“ƒX‚©‚çŠw‚ԗΓàá
‘æ33‰ñ“ú–{—ΓàáŠw‰ï@ƒ”ƒBƒAƒgƒŠƒX»–ò‹¤Ãƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[
—ߘa4”N9ŒŽ16-18“ú@ƒpƒVƒtƒBƒR‰¡•l
ˆî’J@‘å
ƒoƒ‹ƒxƒ‹ƒg‚Í‚±‚¤Žg‚¦IŒŒŠÇV¶—Γàá•Ò@—Γàáf’fEŽ¡—Ã`Ž„‚ÌS‚è‚ÆH•v`
‘æ33‰ñ“ú–{—ΓàáŠw‰ï@AMO‹¤ÃƒCƒuƒjƒ“ƒOƒZƒ~ƒi[
—ߘa4”N9ŒŽ16-18“ú@ƒpƒVƒtƒBƒR‰¡•l
ƒoƒ‹ƒxƒ‹ƒg‚Í‚±‚¤Žg‚¦IŒŒŠÇV¶—Γàá•Ò@—Γàáf’fEŽ¡—Ã`Ž„‚ÌS‚è‚ÆH•v`
‘æ33‰ñ“ú–{—ΓàáŠw‰ï@AMO‹¤ÃƒCƒuƒjƒ“ƒOƒZƒ~ƒi[
—ߘa4”N9ŒŽ16-18“ú@ƒpƒVƒtƒBƒR‰¡•l
ˆî’J@‘å
Ž„‚Í‚±‚¤‚µ‚Ä‚¢‚Ü‚·IŽèp‚̃^ƒCƒ~ƒ“ƒO‚ÆpŽ®‘I‘ð@Ž¡—ˉ»‚Ì’n•½‚ðŠJ‚
‘æ33‰ñ“ú–{—ΓàáŠw‰ï@ŽQ“V»–ò‹¤Ãƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[
—ߘa4”N9ŒŽ16-18“ú@ƒpƒVƒtƒBƒR‰¡•l
Ž„‚Í‚±‚¤‚µ‚Ä‚¢‚Ü‚·IŽèp‚̃^ƒCƒ~ƒ“ƒO‚ÆpŽ®‘I‘ð@Ž¡—ˉ»‚Ì’n•½‚ðŠJ‚
‘æ33‰ñ“ú–{—ΓàáŠw‰ï@ŽQ“V»–ò‹¤Ãƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[
—ߘa4”N9ŒŽ16-18“ú@ƒpƒVƒtƒBƒR‰¡•l
ˆî’J@‘å
ƒŠƒpƒXƒWƒ‹‚Í–[…‚Ì—¬‚ê‚ð•Ï‚¦‚ç‚ê‚é‚©H`Žå—¬o˜H‚ÌŽ¡—Ãí—ª
—Γàá–ò•¨Ž¡—ÂÌVí—ª
‘æ76‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï@‹»˜aŠ”Ž®‰ïŽÐ‹¤Ãƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[
—ߘa4”N10ŒŽ13-16“ú@“Œ‹ž‘ÛƒtƒH[ƒ‰ƒ€
ƒŠƒpƒXƒWƒ‹‚Í–[…‚Ì—¬‚ê‚ð•Ï‚¦‚ç‚ê‚é‚©H`Žå—¬o˜H‚ÌŽ¡—Ãí—ª
—Γàá–ò•¨Ž¡—ÂÌVí—ª
‘æ76‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï@‹»˜aŠ”Ž®‰ïŽÐ‹¤Ãƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[
—ߘa4”N10ŒŽ13-16“ú@“Œ‹ž‘ÛƒtƒH[ƒ‰ƒ€
ˆî’J@‘å
”F—e«‚ðl—¶‚µ‚ÄŽg‚¢‚±‚È‚·
—Γàá–ò•¨Ž¡—Ã@”z‡Ü‚ðŽg‚¢‚±‚È‚·I
‘æ76‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï@çŽõ»–ò‹¤Ãƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[
—ߘa4”N10ŒŽ13-16“ú@“Œ‹ž‘ÛƒtƒH[ƒ‰ƒ€
”F—e«‚ðl—¶‚µ‚ÄŽg‚¢‚±‚È‚·
—Γàá–ò•¨Ž¡—Ã@”z‡Ü‚ðŽg‚¢‚±‚È‚·I
‘æ76‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï@çŽõ»–ò‹¤Ãƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[
—ߘa4”N10ŒŽ13-16“ú@“Œ‹ž‘ÛƒtƒH[ƒ‰ƒ€
ˆî’J@‘å
iStent inject W‚ÌŽg—p¬Ñ’²¸‚𑬕ñ‚µ‚Ü‚·I
‘Šú—Γàá‚ւ̃Aƒvƒ[ƒ``”’“àáŽèp•¹—pŠá“àƒhƒŒ[ƒ“`
‘æ76‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï@ƒOƒ‰ƒEƒRƒXƒWƒƒƒpƒ“‹¤Ãƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[
—ߘa4”N10ŒŽ13-16“ú@“Œ‹ž‘ÛƒtƒH[ƒ‰ƒ€
iStent inject W‚ÌŽg—p¬Ñ’²¸‚𑬕ñ‚µ‚Ü‚·I
‘Šú—Γàá‚ւ̃Aƒvƒ[ƒ``”’“àáŽèp•¹—pŠá“àƒhƒŒ[ƒ“`
‘æ76‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï@ƒOƒ‰ƒEƒRƒXƒWƒƒƒpƒ“‹¤Ãƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[
—ߘa4”N10ŒŽ13-16“ú@“Œ‹ž‘ÛƒtƒH[ƒ‰ƒ€
îà‘º@‰ÀO
RVEGFŽ¡—Âɔ½‰ž«‚Ì’á‚¢“œ”A•a‰©”Á•‚Žî‚Ì“ä‚É”—‚é
‘æ28‰ñ“ú–{“œ”A•aŠáŠw‰ï‘‰ï@ƒmƒoƒ‹ƒeƒBƒXƒtƒ@[ƒ}‹¤Ãƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[
—ߘa4”N10ŒŽ21“ú-22“ú@‘—§‹ž“s‘Û‰ïŠÙ
RVEGFŽ¡—Âɔ½‰ž«‚Ì’á‚¢“œ”A•a‰©”Á•‚Žî‚Ì“ä‚É”—‚é
‘æ28‰ñ“ú–{“œ”A•aŠáŠw‰ï‘‰ï@ƒmƒoƒ‹ƒeƒBƒXƒtƒ@[ƒ}‹¤Ãƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[
—ߘa4”N10ŒŽ21“ú-22“ú@‘—§‹ž“s‘Û‰ïŠÙ
îà‘º@‰ÀO
ƒoƒr[ƒXƒ‚‚ª‚à‚½‚ç‚·DMEŽ¡—Âɂ¨‚¯‚éV“WŠJ
‘æ61‰ñ“ú–{–Ô–ŒÉŽq‘ÌŠw‰ï‘‰ï@’†ŠO»–ò‹¤ÃƒCƒuƒjƒ“ƒOƒZƒ~ƒi[
—ߘa4”N12ŒŽ2-4“ú@‘åã‘Û‰ï‹cê
ƒoƒr[ƒXƒ‚‚ª‚à‚½‚ç‚·DMEŽ¡—Âɂ¨‚¯‚éV“WŠJ
‘æ61‰ñ“ú–{–Ô–ŒÉŽq‘ÌŠw‰ï‘‰ï@’†ŠO»–ò‹¤ÃƒCƒuƒjƒ“ƒOƒZƒ~ƒi[
—ߘa4”N12ŒŽ2-4“ú@‘åã‘Û‰ï‹cê
îà‘º@‰ÀO
‰æ‘œ‰ð͂̉ž—p‚É‚æ‚é“«–Ô–ŒŽ¾Š³‚Ö‚ÌV‚µ‚¢ƒAƒvƒ[ƒ`
‘æ61‰ñ“ú–{–Ô–ŒÉŽq‘ÌŠw‰ï‘‰ï@“ú–{ƒAƒ‹ƒRƒ“‹¤Ãƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[
—ߘa4”N12ŒŽ2-4“ú@‘åã‘Û‰ï‹cê
‰æ‘œ‰ð͂̉ž—p‚É‚æ‚é“«–Ô–ŒŽ¾Š³‚Ö‚ÌV‚µ‚¢ƒAƒvƒ[ƒ`
‘æ61‰ñ“ú–{–Ô–ŒÉŽq‘ÌŠw‰ï‘‰ï@“ú–{ƒAƒ‹ƒRƒ“‹¤Ãƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[
—ߘa4”N12ŒŽ2-4“ú@‘åã‘Û‰ï‹cê
ˆî’J@‘å
ƒuƒŠƒ‚ƒjƒWƒ“/ƒ`ƒ‚ƒ[ƒ‹”z‡“_ŠáÜ‚Ì‘½Ž{Ý‹¤“¯–³ìˆ×‰»ƒNƒƒXƒI[ƒo[ŽŽŒ±
‘æ126‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï
—ߘa4”N4ŒŽ14-17“ú@‘åã‘Û‰ï‹cê
ƒuƒŠƒ‚ƒjƒWƒ“/ƒ`ƒ‚ƒ[ƒ‹”z‡“_ŠáÜ‚Ì‘½Ž{Ý‹¤“¯–³ìˆ×‰»ƒNƒƒXƒI[ƒo[ŽŽŒ±
‘æ126‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï
—ߘa4”N4ŒŽ14-17“ú@‘åã‘Û‰ï‹cê
܈ä@—C‰î
Aqueous column changes after the instillation of ripasudil and latanoprost
ƒŠƒpƒXƒWƒ‹‚¨‚æ‚у‰ƒ^ƒmƒvƒƒXƒg“_ŠáŒã‚Ìã‹–ŒÃ–¬’†‚ÌAqueous column‚̕ω»
‘æ33‰ñ“ú–{—ΓàáŠw‰ï
—ߘa4”N9ŒŽ16-18“ú@ƒpƒVƒtƒBƒR‰¡•l
Aqueous column changes after the instillation of ripasudil and latanoprost
ƒŠƒpƒXƒWƒ‹‚¨‚æ‚у‰ƒ^ƒmƒvƒƒXƒg“_ŠáŒã‚Ìã‹–ŒÃ–¬’†‚ÌAqueous column‚̕ω»
‘æ33‰ñ“ú–{—ΓàáŠw‰ï
—ߘa4”N9ŒŽ16-18“ú@ƒpƒVƒtƒBƒR‰¡•l
Šâí•@Œ’‘¾˜Y
Comparing Surgical Outcomes in Neovascular Glaucoma between Tube and Trabeculectomy: A Multicenter Study
‘æ33‰ñ“ú–{—ΓàáŠw‰ï
—ߘa4”N9ŒŽ16-18“ú@ƒpƒVƒtƒBƒR‰¡•l
Comparing Surgical Outcomes in Neovascular Glaucoma between Tube and Trabeculectomy: A Multicenter Study
‘æ33‰ñ“ú–{—ΓàáŠw‰ï
—ߘa4”N9ŒŽ16-18“ú@ƒpƒVƒtƒBƒR‰¡•l
™Œ´@—F‰ÀA‚‘º@‰ÀO
•Ÿˆä‘åŠw‚É‚¨‚¯‚éƒ[ƒrƒWƒ‡ƒ“ŠO—ˆ‚ÌŽæ‚è‘g‚Ý
‘æ23‰ñ“ú–{ƒ[ƒrƒWƒ‡ƒ“Šw‰ïŠwp‘‰ï
—ߘa4”N5ŒŽ20-22“ú@ŽŽ™“‡Žs
•Ÿˆä‘åŠw‚É‚¨‚¯‚éƒ[ƒrƒWƒ‡ƒ“ŠO—ˆ‚ÌŽæ‚è‘g‚Ý
‘æ23‰ñ“ú–{ƒ[ƒrƒWƒ‡ƒ“Šw‰ïŠwp‘‰ï
—ߘa4”N5ŒŽ20-22“ú@ŽŽ™“‡Žs
’Ò@—²G
L-ƒJƒ‹ƒmƒVƒ“‚ÌŒoŒû“Š—^‚É‚æ‚èCD157ƒmƒbƒNƒAƒEƒgƒ}ƒEƒX‚̎Љï”FŽ¯áŠQ‚ª‰ü‘P‚·‚é
Oral supplementation with L-carnosine attenuates social recognition deficits in CD157KO mice via oxytocin release
Neuro2022 ‘æ45‰ñ“ú–{_Œo‰ÈŠw‘å‰ï^‘æ65‰ñ“ú–{_Œo‰»Šw‰ï‘å‰ï^
‘æ32‰ñ“ú–{_Œo‰ñ˜HŠw‰ï‘å‰ï ‡“¯‘å‰ï
—ߘa4”N6ŒŽ30“ú-7ŒŽ3“ú@‰«“ꌧ
L-ƒJƒ‹ƒmƒVƒ“‚ÌŒoŒû“Š—^‚É‚æ‚èCD157ƒmƒbƒNƒAƒEƒgƒ}ƒEƒX‚̎Љï”FŽ¯áŠQ‚ª‰ü‘P‚·‚é
Oral supplementation with L-carnosine attenuates social recognition deficits in CD157KO mice via oxytocin release
Neuro2022 ‘æ45‰ñ“ú–{_Œo‰ÈŠw‘å‰ï^‘æ65‰ñ“ú–{_Œo‰»Šw‰ï‘å‰ï^
‘æ32‰ñ“ú–{_Œo‰ñ˜HŠw‰ï‘å‰ï ‡“¯‘å‰ï
—ߘa4”N6ŒŽ30“ú-7ŒŽ3“ú@‰«“ꌧ
‘哈@GK
“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚éRVEGFŽ¡—ÃŒã‚ÌŒŒ“œƒRƒ“ƒgƒ[ƒ‹‚ɂ‚¢‚Ä
‘æ28‰ñ“ú–{“œ”A•aŠáŠw‰ï‘‰ï
—ߘa4”N10ŒŽ21“ú-22“ú@‘—§‹ž“s‘Û‰ïŠÙ
“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚éRVEGFŽ¡—ÃŒã‚ÌŒŒ“œƒRƒ“ƒgƒ[ƒ‹‚ɂ‚¢‚Ä
‘æ28‰ñ“ú–{“œ”A•aŠáŠw‰ï‘‰ï
—ߘa4”N10ŒŽ21“ú-22“ú@‘—§‹ž“s‘Û‰ïŠÙ
ŽR“c@—Y‹M
“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚éRVEGFŽ¡—Ã
‘æ28‰ñ“ú–{“œ”A•aŠáŠw‰ï‘‰ï
—ߘa4”N10ŒŽ21“ú-22“ú@‘—§‹ž“s‘Û‰ïŠÙ
“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚éRVEGFŽ¡—Ã
‘æ28‰ñ“ú–{“œ”A•aŠáŠw‰ï‘‰ï
—ߘa4”N10ŒŽ21“ú-22“ú@‘—§‹ž“s‘Û‰ïŠÙ
—L‘º@®Œå
üˆÛ’Œ‘ÑØœp‚Æ”’“àá‚ÌŠÖŒW
–k—¤—ΓàáƒZƒ~ƒi[ from•ŸƒCƒCI
—ߘa4”N4ŒŽ21“ú@•ŸˆäŽs iWEBŠJÃ)
üˆÛ’Œ‘ÑØœp‚Æ”’“àá‚ÌŠÖŒW
–k—¤—ΓàáƒZƒ~ƒi[ from•ŸƒCƒCI
—ߘa4”N4ŒŽ21“ú@•ŸˆäŽs iWEBŠJÃ)
ˆî’J@‘å
ƒGƒNƒXƒgƒŠ[ƒ€I—ΓàᎡ—Ã@ŒŒŠÇV¶—Γàá•Ò
‘æ29‰ñHOT
—ߘa4”N4ŒŽ22“ú@“Œ‹ž“s
ƒGƒNƒXƒgƒŠ[ƒ€I—ΓàᎡ—Ã@ŒŒŠÇV¶—Γàá•Ò
‘æ29‰ñHOT
—ߘa4”N4ŒŽ22“ú@“Œ‹ž“s
ˆî’J@‘å
ƒGƒNƒXƒgƒŠ[ƒ€I—ΓàáŽèp@`MIGS•Ò`
‘æ13‰ñ¹ƒ}ƒŠƒAƒ“ƒiŠá‰È—Õ°ƒtƒH[ƒ‰ƒ€
—ߘa4”N5ŒŽ14“ú@_“Þ쌧ìèŽs
ƒGƒNƒXƒgƒŠ[ƒ€I—ΓàáŽèp@`MIGS•Ò`
‘æ13‰ñ¹ƒ}ƒŠƒAƒ“ƒiŠá‰È—Õ°ƒtƒH[ƒ‰ƒ€
—ߘa4”N5ŒŽ14“ú@_“Þ쌧ìèŽs
ˆî’J@‘å
ƒGƒNƒXƒgƒŠ[ƒ€I—Γàá–ò•¨Ž¡—Ã`ƒKƒCƒhƒ‰ƒCƒ“•Ò`
“ì‘åãƒAƒCƒtƒH[ƒ‰ƒ€
—ߘa4”N6ŒŽ2“ú@‘åã•{äŽs
ƒGƒNƒXƒgƒŠ[ƒ€I—Γàá–ò•¨Ž¡—Ã`ƒKƒCƒhƒ‰ƒCƒ“•Ò`
“ì‘åãƒAƒCƒtƒH[ƒ‰ƒ€
—ߘa4”N6ŒŽ2“ú@‘åã•{äŽs
îà‘º@‰ÀO
“œ”A•a‰©”Á•‚Žî‚Ì‘SgŠÇ—
Novartis DME Web Seminar
—ߘa4”N6ŒŽ2“ú@WEB”zM
“œ”A•a‰©”Á•‚Žî‚Ì‘SgŠÇ—
Novartis DME Web Seminar
—ߘa4”N6ŒŽ2“ú@WEB”zM
ˆî’J@‘å
y‚ä‚Á‚‚è‰ðàzƒAƒCƒx[ƒ^“Á’è—Õ°Œ¤‹†
SENJU Web Seminar
—ߘa4”N6ŒŽ23“ú@•ŸˆäŒ§‚©‚ç‘S‘Web”zM
y‚ä‚Á‚‚è‰ðàzƒAƒCƒx[ƒ^“Á’è—Õ°Œ¤‹†
SENJU Web Seminar
—ߘa4”N6ŒŽ23“ú@•ŸˆäŒ§‚©‚ç‘S‘Web”zM
ˆî’J@‘å
y‚ä‚Á‚‚è‰ðàz—Γàá“_Šá–ò2022
‘æ153‰ñL“‡Œ§Šá‰Èˆã‰ïuK‰ï
—ߘa4”N7ŒŽ3“ú@L“‡Žs
y‚ä‚Á‚‚è‰ðàz—Γàá“_Šá–ò2022
‘æ153‰ñL“‡Œ§Šá‰Èˆã‰ïuK‰ï
—ߘa4”N7ŒŽ3“ú@L“‡Žs
îà‘º@‰ÀO
ƒKƒCƒhƒ‰ƒCƒ“‚ÉŠî‚“œ”A•a–Ô–ŒÇE‰©”Á•‚Žî‚ɑ΂·‚鎡—Ã
Shimbashi Ophthalmic Seminar
—ߘa4”N7ŒŽ4“ú@Web”zM
ƒKƒCƒhƒ‰ƒCƒ“‚ÉŠî‚“œ”A•a–Ô–ŒÇE‰©”Á•‚Žî‚ɑ΂·‚鎡—Ã
Shimbashi Ophthalmic Seminar
—ߘa4”N7ŒŽ4“ú@Web”zM
ˆî’J@‘å
ƒOƒ‰ƒiƒeƒbƒN‚ª–[…‚Ì—¬‚ê‚ð•Ï‚¦‚éI`Žå—¬o˜H‚ÌŽ¡—Ãí—ª`
ƒOƒ‰ƒiƒeƒbƒN Web ƒJƒ“ƒtƒ@ƒŒƒ“ƒX
—ߘa4”N9ŒŽ29“ú@“Œ‹ž“s‚©‚ç‘S‘Web”zM
ƒOƒ‰ƒiƒeƒbƒN‚ª–[…‚Ì—¬‚ê‚ð•Ï‚¦‚éI`Žå—¬o˜H‚ÌŽ¡—Ãí—ª`
ƒOƒ‰ƒiƒeƒbƒN Web ƒJƒ“ƒtƒ@ƒŒƒ“ƒX
—ߘa4”N9ŒŽ29“ú@“Œ‹ž“s‚©‚ç‘S‘Web”zM
îà‘º@‰ÀO
Ž¡—Ã’ïR«‚Ì“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚éRVEGF—Ö@‚ðl‚¦‚é
‘æ6‰ñƒAƒCƒŠ[ƒA‰©”ÁŽ¾Š³ƒZƒ~ƒi[in²‰ê
—ߘa4”N10ŒŽ1“ú@Web”zM
Ž¡—Ã’ïR«‚Ì“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚éRVEGF—Ö@‚ðl‚¦‚é
‘æ6‰ñƒAƒCƒŠ[ƒA‰©”ÁŽ¾Š³ƒZƒ~ƒi[in²‰ê
—ߘa4”N10ŒŽ1“ú@Web”zM
îà‘º@‰ÀO
“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚éRVEGFŽ¡—Âɂ¨‚¯‚é”Y‚Ý‚Æ‘ÅŠJô
‘æ2‰ñ’z’nƒIƒtƒTƒ‹ƒ~ƒbƒNƒZƒ~ƒi[
—ߘa4”N10ŒŽ6“ú@Web”zM
“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚éRVEGFŽ¡—Âɂ¨‚¯‚é”Y‚Ý‚Æ‘ÅŠJô
‘æ2‰ñ’z’nƒIƒtƒTƒ‹ƒ~ƒbƒNƒZƒ~ƒi[
—ߘa4”N10ŒŽ6“ú@Web”zM
ŽR“c@—Y‹M
“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚éRVEGFŽ¡—Âł̖ԖŒŒú‰ü‘P—¦‚Ì•”ˆÊ•Ê‘Šˆá
‘æ7‰ñŽáŽèDRŒ¤‹†‰ï
—ߘa4”N10ŒŽ21“ú@‹ž“sŽs
“œ”A•a‰©”Á•‚Žî‚ɑ΂·‚éRVEGFŽ¡—Âł̖ԖŒŒú‰ü‘P—¦‚Ì•”ˆÊ•Ê‘Šˆá
‘æ7‰ñŽáŽèDRŒ¤‹†‰ï
—ߘa4”N10ŒŽ21“ú@‹ž“sŽs
Œã‘ò@½
MPS–@‚ð‰ž—p‚µ‚½3DÉŽq‘Ìo‚É‚¨‚¯‚éretro-oil fluid‚Ì‹““®‰ðÍ
Prometech Simulation Conference 2022
—ߘa4”N11ŒŽ9“ú@Web”zM
MPS–@‚ð‰ž—p‚µ‚½3DÉŽq‘Ìo‚É‚¨‚¯‚éretro-oil fluid‚Ì‹““®‰ðÍ
Prometech Simulation Conference 2022
—ߘa4”N11ŒŽ9“ú@Web”zM
ˆî’J@‘å
ƒGƒNƒXƒgƒŠ[ƒ€I—Γàá–ò•¨Ž¡—Ã`ƒKƒCƒhƒ‰ƒCƒ“•Ò`
‘æ20‰ñ‚’mŠá‰ŠÇŒ¤‹†‰ï@
—ߘa4”N11ŒŽ12“ú@‚’mŽs
ƒGƒNƒXƒgƒŠ[ƒ€I—Γàá–ò•¨Ž¡—Ã`ƒKƒCƒhƒ‰ƒCƒ“•Ò`
‘æ20‰ñ‚’mŠá‰ŠÇŒ¤‹†‰ï@
—ߘa4”N11ŒŽ12“ú@‚’mŽs
¼‘º@Œ’‘å
Š´õ«Šp–Œ‰Š‚Ì‘OŠá•”‰æ‘œŒŸ¸
‘æ46‰ñCOST
—ߘa4”N11ŒŽ15“ú@Web”zM
Š´õ«Šp–Œ‰Š‚Ì‘OŠá•”‰æ‘œŒŸ¸
‘æ46‰ñCOST
—ߘa4”N11ŒŽ15“ú@Web”zM
ˆî’J@‘å
u‚ä‚Á‚‚è‰ðàv—Γàá“_Šá–ò2022
‘æ11‰ñ“ÈŠáˆãàÕ‹¦Šá‰È•af˜AŒg‚̉ï@
—ߘa4”N11ŒŽ17“ú@“È–ØŒ§‰F“s‹{Žs
u‚ä‚Á‚‚è‰ðàv—Γàá“_Šá–ò2022
‘æ11‰ñ“ÈŠáˆãàÕ‹¦Šá‰È•af˜AŒg‚̉ï@
—ߘa4”N11ŒŽ17“ú@“È–ØŒ§‰F“s‹{Žs
ˆî’J@‘å
ƒ`ƒ…[ƒuƒVƒƒƒ“ƒgŽèp‚ɂ‚¢‚Ä
“Œ‹ž‘åŠwE•Ÿˆä‘åŠwJoint Glaucoma Conference
—ߘa4”N12ŒŽ14“ú@Web”zM
ƒ`ƒ…[ƒuƒVƒƒƒ“ƒgŽèp‚ɂ‚¢‚Ä
“Œ‹ž‘åŠwE•Ÿˆä‘åŠwJoint Glaucoma Conference
—ߘa4”N12ŒŽ14“ú@Web”zM
ˆî’J@‘å
Å‘¬‚Å‚í‚©‚éNVGŽÀ—Õ°
KANSAI RVO/NVG WEB SEMINAR 2022
—ߘa4”N12ŒŽ15“ú@‹ß‹E’n‹æ‚ÖWeb”zM
Å‘¬‚Å‚í‚©‚éNVGŽÀ—Õ°
KANSAI RVO/NVG WEB SEMINAR 2022
—ߘa4”N12ŒŽ15“ú@‹ß‹E’n‹æ‚ÖWeb”zM
ˆî’J@‘å
y‚ä‚Á‚‚è‰ðàz—Γàá“_Šá–ò2023
‘æ19‰ñÓìŠá‰È‹äŠy•”
—ߘa5”N1ŒŽ12“ú@_“Þ쌧Š™‘qŽs
y‚ä‚Á‚‚è‰ðàz—Γàá“_Šá–ò2023
‘æ19‰ñÓìŠá‰È‹äŠy•”
—ߘa5”N1ŒŽ12“ú@_“Þ쌧Š™‘qŽs
ˆî’J@‘å
y‚ä‚Á‚‚è‰ðàz—ΓàáŽèpŽ¡—Ã2023
•Ÿ‰ªŒ§Šá‰ÈŠwWebƒZƒ~ƒi[
—ߘa5”N1ŒŽ19“ú@•Ÿ‰ªŒ§‚ÖWeb”zM
y‚ä‚Á‚‚è‰ðàz—ΓàáŽèpŽ¡—Ã2023
•Ÿ‰ªŒ§Šá‰ÈŠwWebƒZƒ~ƒi[
—ߘa5”N1ŒŽ19“ú@•Ÿ‰ªŒ§‚ÖWeb”zM
ˆî’J@‘å
y‚ä‚Á‚‚è‰ðàz—Γàá‚ÌÏ‹ÉŽ¡—Ã
SENJU Web Seminar
—ߘa5”N1ŒŽ20“ú@•ŸˆäŒ§‚©‚ç‘S‘‚ÖWeb”zM
y‚ä‚Á‚‚è‰ðàz—Γàá‚ÌÏ‹ÉŽ¡—Ã
SENJU Web Seminar
—ߘa5”N1ŒŽ20“ú@•ŸˆäŒ§‚©‚ç‘S‘‚ÖWeb”zM
ˆî’J@‘å
[‚ä‚Á‚‚è‰ðà]’´‚—ŽÐ‰ï‚̗ΓàáŽèp
‘æ363‰ñŠâŽèŠá‰ÈW’k‰ï
—ߘa5”N1ŒŽ21“ú@ŠâŽèŒ§·‰ªŽs
[‚ä‚Á‚‚è‰ðà]’´‚—ŽÐ‰ï‚̗ΓàáŽèp
‘æ363‰ñŠâŽèŠá‰ÈW’k‰ï
—ߘa5”N1ŒŽ21“ú@ŠâŽèŒ§·‰ªŽs
îà‘º@‰ÀO
DME‚ɑ΂·‚éRVEGF–ò‚Ì•p‰ñ“Š—^‚ɂ‚¢‚ÄÄl‚·‚é
‘æ8‰ñŽŽ™“‡ŠáŽ¾Š³ƒtƒH[ƒ‰ƒ€
—ߘa5”N1ŒŽ21“ú@ŽŽ™“‡Œ§
DME‚ɑ΂·‚éRVEGF–ò‚Ì•p‰ñ“Š—^‚ɂ‚¢‚ÄÄl‚·‚é
‘æ8‰ñŽŽ™“‡ŠáŽ¾Š³ƒtƒH[ƒ‰ƒ€
—ߘa5”N1ŒŽ21“ú@ŽŽ™“‡Œ§
Šâí•@Œ’‘¾˜Y
Šá‰ÈƒXƒ^ƒbƒt•KŒ©I—ΓàáŽèp‚ð®—‚·‚é
Šá‰ÈƒXƒ^ƒbƒtƒZƒ~ƒi[in•Ÿˆä@
—ߘa5”N1ŒŽ25“ú Web”zM
Šá‰ÈƒXƒ^ƒbƒt•KŒ©I—ΓàáŽèp‚ð®—‚·‚é
Šá‰ÈƒXƒ^ƒbƒtƒZƒ~ƒi[in•Ÿˆä@
—ߘa5”N1ŒŽ25“ú Web”zM
îà‘º@‰ÀO
“œ”A•a‰©”Á•‚Žî@‹‚ß‚ç‚ê‚é“à‰È‚ÆŠá‰È‚̘AŒg
“à‰È‚ÆŠá‰È‚̈ã—ØAŒg‚ðl‚¦‚é`V‚µ‚¢t«•nŒŒŽ¡—Öò‚𓥂܂¦‚Ä`
—ߘa5”N2ŒŽ3“ú@•Ÿˆä¤H‰ï‹cŠ
“œ”A•a‰©”Á•‚Žî@‹‚ß‚ç‚ê‚é“à‰È‚ÆŠá‰È‚̘AŒg
“à‰È‚ÆŠá‰È‚̈ã—ØAŒg‚ðl‚¦‚é`V‚µ‚¢t«•nŒŒŽ¡—Öò‚𓥂܂¦‚Ä`
—ߘa5”N2ŒŽ3“ú@•Ÿˆä¤H‰ï‹cŠ
ˆî’J@‘å
y‚ä‚Á‚‚è‰ðàz—Γàá“_Šá–ò2023
‘æ13‰ñɪŒ§Šá‰ÈƒtƒH[ƒ‰ƒ€
—ߘa5”N2ŒŽ18“ú@ɪŽs
y‚ä‚Á‚‚è‰ðàz—Γàá“_Šá–ò2023
‘æ13‰ñɪŒ§Šá‰ÈƒtƒH[ƒ‰ƒ€
—ߘa5”N2ŒŽ18“ú@ɪŽs
ˆî’J@‘å
y‚ä‚Á‚‚è‰ðàz—Γàá”z‡“_Šá–ò2023
Kowa WebƒJƒ“ƒtƒ@ƒŒƒ“ƒX ’}Œã—Γàáu‰‰‰ï
—ߘa5”N2ŒŽ28“ú@•Ÿ‰ªŒ§‚ÖWeb”zM
y‚ä‚Á‚‚è‰ðàz—Γàá”z‡“_Šá–ò2023
Kowa WebƒJƒ“ƒtƒ@ƒŒƒ“ƒX ’}Œã—Γàáu‰‰‰ï
—ߘa5”N2ŒŽ28“ú@•Ÿ‰ªŒ§‚ÖWeb”zM
ˆî’J@‘å
y‚ä‚Á‚‚è‰ðàz—ΓàáŽèpŽ¡—Ã2023
L“‡Œ§Šá‰ÈŠwWebƒZƒ~ƒi[@
—ߘa5”N3ŒŽ16“ú@L“‡Žs‚ÖWEB”zM
y‚ä‚Á‚‚è‰ðàz—ΓàáŽèpŽ¡—Ã2023
L“‡Œ§Šá‰ÈŠwWebƒZƒ~ƒi[@
—ߘa5”N3ŒŽ16“ú@L“‡Žs‚ÖWEB”zM
Žs‹´ —SŽuAŒã‘ò ½A‚‘º ‰ÀOAÂ–Ø •üŒbAŠâè Œ’‘¾˜YA
ˆî’J ‘å
Computational fluid dynamics (CFD) simulation analysis on retinal gas cover rates using computational eye models
‘æ348‰ñ‹à‘òŠá‰ÈW’k‰ï@—ߘa4”N4ŒŽ24“ú@‹à‘òŽs
ˆî’J ‘å
Computational fluid dynamics (CFD) simulation analysis on retinal gas cover rates using computational eye models
‘æ348‰ñ‹à‘òŠá‰ÈW’k‰ï@—ߘa4”N4ŒŽ24“ú@‹à‘òŽs
Œã‘ò@½
Application of moving particle semi-implicit(MPS)method on retro-oil fluid using three-dimentional vitreous cavity models from magnetic resonance imaging
‘æ6‰ñ–k—¤4‘åŠwŠá‰È‡“¯Œ¤‹†‰ï@—ߘa4”N6ŒŽ3“ú@‹à‘òŽs@WEB”zM
Application of moving particle semi-implicit(MPS)method on retro-oil fluid using three-dimentional vitreous cavity models from magnetic resonance imaging
‘æ6‰ñ–k—¤4‘åŠwŠá‰È‡“¯Œ¤‹†‰ï@—ߘa4”N6ŒŽ3“ú@‹à‘òŽs@WEB”zM
Žs‹´ —SŽuAŒã‘ò ½A‚‘º ‰ÀOAÂ–Ø •üŒbAŠâí•Œ’‘¾˜YAˆî’J ‘å
Computational fluid dynamics (CFD) simulation analysis on retinal gas cover rates using computational eye models
‘æ85‰ñ•xŽRŠá‰ÈW’k‰ï@—ߘa4”N6ŒŽ12“ú@•xŽRŽs‚æ‚èWEB”zM
Computational fluid dynamics (CFD) simulation analysis on retinal gas cover rates using computational eye models
‘æ85‰ñ•xŽRŠá‰ÈW’k‰ï@—ߘa4”N6ŒŽ12“ú@•xŽRŽs‚æ‚èWEB”zM
܈ä@—C‰î
ƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“ŠÖ˜A–ò‚Æ‚Ì•¹—p—Ö@‚Æ‚µ‚Ä‚ÌAƒuƒŠƒ‚ƒjƒWƒ“0.1“^ƒ`ƒ‚ƒ[ƒ‹0.5“‚ƃhƒ‹ƒ]ƒ‰ƒ~ƒh1“^ƒ`ƒ‚ƒ[ƒ‹0.5“‡Ü‚Ì—LŒø«‚Æ”E—e«‚Ì”äŠrŒŸ“¢FAibeta Crossover Study
‘æ7‰ñAGTS‚̉ï@—ߘa4”N7ŒŽ8“ú@WEB”zM
ƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“ŠÖ˜A–ò‚Æ‚Ì•¹—p—Ö@‚Æ‚µ‚Ä‚ÌAƒuƒŠƒ‚ƒjƒWƒ“0.1“^ƒ`ƒ‚ƒ[ƒ‹0.5“‚ƃhƒ‹ƒ]ƒ‰ƒ~ƒh1“^ƒ`ƒ‚ƒ[ƒ‹0.5“‡Ü‚Ì—LŒø«‚Æ”E—e«‚Ì”äŠrŒŸ“¢FAibeta Crossover Study
‘æ7‰ñAGTS‚̉ï@—ߘa4”N7ŒŽ8“ú@WEB”zM
Žs‹´ —SŽuAŒã‘ò ½A‚‘º ‰ÀOAÂ–Ø •üŒbAŠâí• Œ’‘¾˜YA
ˆî’J ‘å
Computational fluid dynamics (CFD) simulation analysis on retinal gas cover rates using computational eye models
‘æ75‰ñ•ŸˆäŒ§Šá‰ÈW’k‰ï@—ߘa4”N9ŒŽ3“ú@•ŸˆäŽs
ˆî’J ‘å
Computational fluid dynamics (CFD) simulation analysis on retinal gas cover rates using computational eye models
‘æ75‰ñ•ŸˆäŒ§Šá‰ÈW’k‰ï@—ߘa4”N9ŒŽ3“ú@•ŸˆäŽs
“c’†@Œ’ŒåA—é–Ø –œ—ŒbAÜˆä —C‰îA—é–Ø—z•½A¬X—Á•½A
—L‘º ®ŒåAŠâí• Œ’‘¾˜YAîà‘º ‰ÀOAˆî’J ‘å
ƒŠƒpƒXƒWƒ‹‚¨‚æ‚у‰ƒ^ƒmƒvƒƒXƒg“_ŠáŒã‚Ìã‹–ŒÃ–¬‚É‚¨‚¯‚é–[…ƒJƒ‰ƒ€‚̕ω»
‘æ42‰ñ‹à‘òˆã‰È‘åŠwŠá‰ÈŒ¤‹†‰ï@—ߘa4”N11ŒŽ6“ú@‹à‘òŽs
—L‘º ®ŒåAŠâí• Œ’‘¾˜YAîà‘º ‰ÀOAˆî’J ‘å
ƒŠƒpƒXƒWƒ‹‚¨‚æ‚у‰ƒ^ƒmƒvƒƒXƒg“_ŠáŒã‚Ìã‹–ŒÃ–¬‚É‚¨‚¯‚é–[…ƒJƒ‰ƒ€‚̕ω»
‘æ42‰ñ‹à‘òˆã‰È‘åŠwŠá‰ÈŒ¤‹†‰ï@—ߘa4”N11ŒŽ6“ú@‹à‘òŽs
“c’†@Œ’ŒåA—é–Ø –œ—ŒbAÜˆä —C‰îA—é–Ø—z•½A¬X—Á•½A
—L‘º ®ŒåAŠâí• Œ’‘¾˜YAîà‘º ‰ÀOAˆî’J ‘å
ƒŠƒpƒXƒWƒ‹‚¨‚æ‚у‰ƒ^ƒmƒvƒƒXƒg“_ŠáŒã‚Ìã‹–ŒÃ–¬‚É‚¨‚¯‚é–[…ƒJƒ‰ƒ€‚̕ω»
‘æ86‰ñ•xŽRŠá‰ÈW’k‰ï@—ߘa4”N11ŒŽ23“ú@•xŽRŽsiƒnƒCƒuƒŠƒbƒhŠJÃj
—L‘º ®ŒåAŠâí• Œ’‘¾˜YAîà‘º ‰ÀOAˆî’J ‘å
ƒŠƒpƒXƒWƒ‹‚¨‚æ‚у‰ƒ^ƒmƒvƒƒXƒg“_ŠáŒã‚Ìã‹–ŒÃ–¬‚É‚¨‚¯‚é–[…ƒJƒ‰ƒ€‚̕ω»
‘æ86‰ñ•xŽRŠá‰ÈW’k‰ï@—ߘa4”N11ŒŽ23“ú@•xŽRŽsiƒnƒCƒuƒŠƒbƒhŠJÃj
܈ä@—C‰î
ƒAƒCƒx[ƒ^ƒNƒƒXƒI[ƒo[ŽŽŒ±
“Œ‹ž‘åŠwE•Ÿˆä‘åŠwJoint Glaucoma Conference
—ߘa4”N12ŒŽ14“ú@Web”zM
ƒAƒCƒx[ƒ^ƒNƒƒXƒI[ƒo[ŽŽŒ±
“Œ‹ž‘åŠwE•Ÿˆä‘åŠwJoint Glaucoma Conference
—ߘa4”N12ŒŽ14“ú@Web”zM
ˆ¢•”@—DŽ÷A܈ä@—S‰îAŽR“c@—Y‹MA·‰ª@³˜aA
Šâí•@Œ’‘¾˜YA—L‘º@®ŒåAˆî’J@‘å
0.1“ƒuƒŠƒ‚ƒjƒWƒ“ŽðÎŽ_‰–^0.5“ƒ`ƒ‚ƒ[ƒ‹”z‡“_ŠáÜ‚Ìl‘gD‚É‚¨‚¯‚éŠá‘gD•ª•z
‘æ349‰ñ‹à‘òŠá‰ÈW’k‰ï@—ߘa4”N12ŒŽ18“ú@‹à‘òŽs
Šâí•@Œ’‘¾˜YA—L‘º@®ŒåAˆî’J@‘å
0.1“ƒuƒŠƒ‚ƒjƒWƒ“ŽðÎŽ_‰–^0.5“ƒ`ƒ‚ƒ[ƒ‹”z‡“_ŠáÜ‚Ìl‘gD‚É‚¨‚¯‚éŠá‘gD•ª•z
‘æ349‰ñ‹à‘òŠá‰ÈW’k‰ï@—ߘa4”N12ŒŽ18“ú@‹à‘òŽs
Žs‹´@—SŽu
Œ£Šá—v¿Aˆã‹Ç‚Å‚Ç‚¤‘Ήž‚µ‚Ä‚éH
‘æ76‰ñ•ŸˆäŒ§Šá‰ÈW’k‰ï@—ߘa5”N1ŒŽ14“ú@•Ÿˆä¤H‰ï‹cŠ
Œ£Šá—v¿Aˆã‹Ç‚Å‚Ç‚¤‘Ήž‚µ‚Ä‚éH
‘æ76‰ñ•ŸˆäŒ§Šá‰ÈW’k‰ï@—ߘa5”N1ŒŽ14“ú@•Ÿˆä¤H‰ï‹cŠ